<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1645-0086</journal-id>
<journal-title><![CDATA[Psicologia, Saúde & Doenças]]></journal-title>
<abbrev-journal-title><![CDATA[Psic., Saúde & Doenças]]></abbrev-journal-title>
<issn>1645-0086</issn>
<publisher>
<publisher-name><![CDATA[Sociedade Portuguesa de Psicologia da Saúde]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1645-00862008000100008</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Validation study of the portuguese version of the QLC-C30-V.3]]></article-title>
<article-title xml:lang="pt"><![CDATA[Estudo de validação da versão portuguesa do QLQ-C30-V.3]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pais-Ribeiro]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Porto University  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Instituto Politécnico do Porto Escola Superior de Enfermagem ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2008</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2008</year>
</pub-date>
<volume>9</volume>
<numero>1</numero>
<fpage>89</fpage>
<lpage>102</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S1645-00862008000100008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S1645-00862008000100008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S1645-00862008000100008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[The purpose of this research was to study the metric properties of the Portuguese translation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30, version 3). A heterogeneous cancer patient sample of 933 subjects, 61.5% female, mean age 54.24 years, mean school age years of 6.9 years, with a diagnosis from one month to 31 years, was used. The questionnaire seems to be sensitive to cancer sites but not to the number of years with the disease. Mean values for the scales, and reliability are appropriate and show similar patterns to other versions from different cultures and languages. Correlations between scales show moderate correlations suggesting that they measure different and complementary constructs, which constitute important information for clinicians in the followup of this population. We can say that the Portuguese version of the QLQ-C30 has good metric properties, and measures the same constructs, the same way, as the versions from other languages and cultures, and it is appropriate to be applied to people with cancer disease]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[O objectivo da presente investigação é estudar as propriedades métricas da versão Portuguesa do questionário de qualidade de vida da European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core30 (EORTC QLQ-C30, version 3). Participu uma amostra heterogénea de 933 indivíduos com diagnóstico de cancro, 61,5% mulheres, idade média de 54,24 anos, escolaridade média de 6,9 anos, com diagnóstico de cancro entre um mês e 31 anos. O questionário parece ser sensível à localização do cancro mas não ao número de anos com a doença. Os valores médios das escalas e a fidelidade são apropriadas e mostram um padrão semelhante a outras versões de diferentes línguas e culturas. Correlações entre escalas mostram correlações moderadas o que sugere que elas medem construtos diferentes mas complementares, o que constitui informação importante para os clínicos que seguem estes doentes. Podemos dizer que a versão portuguesa do QLQ-C30 possui boas propriedades métricas, e que mede, os mesmos constructos, do mesmo modo, que as versões noutras línguas e culturas, e que é apropriada para ser aplicada com pessoas com cancro]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[EORTC QLQ-C30]]></kwd>
<kwd lng="en"><![CDATA[Cancer disease]]></kwd>
<kwd lng="en"><![CDATA[Quality of life]]></kwd>
<kwd lng="pt"><![CDATA[EORTC QLQ-C30]]></kwd>
<kwd lng="pt"><![CDATA[Doença oncológica]]></kwd>
<kwd lng="pt"><![CDATA[Qualidade de vida]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="center"><b>Validation study of the portuguese version of the QLC-C30-V.3</b>  </p>     <p align="center">&nbsp; </p>     <P align="center"> J. Pais-Ribeiro<Sup>1</Sup>, C. Pinto<Sup>2 </Sup>& C. Santos<Sup>2</Sup></P>     <P align="center"><Sup>1</Sup>Porto University; </P>     <P align="center"><Sup>2</Sup>Escola Superior de Enfermagem I.Politécnico do Porto  </P>     <P align="center">&nbsp;</P>     <p> <b>ABSTRACT:</b> The purpose of this research was to study the metric properties    of the Portuguese translation of the European Organization for Research and    Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30, version    3). A heterogeneous cancer patient sample of 933 subjects, 61.5% female, mean    age 54.24 years, mean school age years of 6.9 years, with a diagnosis from one    month to 31 years, was used. The questionnaire seems to be sensitive to cancer    sites but not to the number of years with the disease. Mean values for the scales,    and reliability are appropriate and show similar patterns to other versions    from different cultures and languages. Correlations between scales show moderate    correlations suggesting that they measure different and complementary constructs,    which constitute important information for clinicians in the followup of this    population. We can say that the Portuguese version of the QLQ-C30 has good metric    properties, and measures the same constructs, the same way, as the versions    from other languages and cultures, and it is appropriate to be applied to people    with cancer disease </P>     <p> Key words: EORTC QLQ-C30, Cancer disease, Quality of life. </P>     <p>&nbsp;</P>     <p align="center"> <b>Estudo de validação da versão portuguesa do QLQ-C30-V.3    </b></p>     ]]></body>
<body><![CDATA[<p> <b>RESUMO:</b> O objective da presente investigação é estudar as propriedades    métricas da versão Portuguesa do questionário de qualidade de vida da European    Organization for Research and Treatment of Cancer Quality of Life Questionnaire    Core30 (EORTC QLQ-C30, version 3). Participu uma amostra heterogénea de 933    indivíduos com diagnóstico de cancro, 61,5% mulheres, idade média de 54,24 anos,    escolaridade média de 6,9 anos, com diagnóstico de cancro entre um mês e 31    anos. O questionário parece ser sensível à localização do cancro mas não ao    número de anos com a doença. Os valores médios das escalas e a fidelidade são    apropriadas e mostram um padrão semelhante a outras versões de diferentes línguas    e culturas. Correlações entre escalas mostram correlações moderadas o que sugere    que elas medem construtos diferentes mas complementares, o que constitui informação    importante para os clínicos que seguem estes doentes. Podemos dizer que a versão    portuguesa do QLQ-C30 possui boas propriedades métricas, e que mede, os mesmos    constructos, do mesmo modo, que as versões noutras línguas e culturas, e que    é apropriada para ser aplicada com pessoas com cancro </P>     <p> Palavras-chave: EORTC QLQ-C30, Doença oncológica, Qualidade de vida. </P>     <p>&nbsp;</P>     <p>&nbsp;</P>     <p>Full text only available in PDF format.</P>     <p>Texto completo disponível apenas em PDF. </P>     <p>&nbsp;</P>     <p>&nbsp;</P>     <p align="center"><b>REFERENCES</b></P>     <!-- ref --><p> Aaronson, N, Ahmedzai, S., Bergman, B., Bullinger, Cull, A, Duez, N. et al.    (1993). The European Organization for Research and Treatment of Cancer QLQ-C30:    A qualityof lifeinstrument for use in international clinical trials in oncology.    Journal of the National Cancer Institute, 85(5), 365-375 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=000022&pid=S1645-0086200800010000800001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p> Alfano, C., & Rowland, J. (2006).Recovery Issues in Cancer Survivorship: A    New Challenge for Supportive Care. The Cancer Journal,12(5), 432-443 </P>     <p> Arraras, J., Arias, F., Tejedor, M., Pruja, E., Marcos,M., Martínez, E., &    Valerdi, J. (2002). The EORTC QLQ-C30 (version 3.0) QoL questionnaire: Validation    study for Spain with head and neck cancer patients. Psycho-Oncology, 11, 249–256  </P>     <p> Avis, N.,Smith, K., McGraw, S., Smith, R., Petronis, V., & Carver, C. (2005).    Assessing Quality of Life in Adult Cancer Survivors (QLACS). Quality of Life    Research, 14, 1007–1023 </P>     <p> Bloom, J. (2002). Surviving and Thriving? PsychoOncology, 11, 89–92 </P>     <p> Bolen & Lenox, 1991) </P>     <P> Cabral, M.V. (Coord.), da Silva, P.A., & Mendes, H. (2002). Saúde e doença    em Portugal. Lisboa: Imprensa de Ciências Sociais. </P>     <p> CDC. (2004). Cancer Survivorship. Atlanta: Centers for Disease Control and    Prevention Centers for Disease Control and Prevention. Assessed in august 2007    in: <a href="http://www.cdc.gov/cancer" target="_blank">http://www.cdc.gov/cancer</a>  </P>     <p> Chie, W., Yang, C., Hsu, C., & Yang, P. (2004). Quality of life of lung cancer    patients: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and    QLQLC13, Quality of Life Research, 13, 257–262. </P>     <p> Fayers, P.M., Hand, D.J., Bjordal, K., & Groenvold,M. (1997). Causal indicators    in quality of life research. Quality of Life Research, 6, 393–406 </P>     <p> Fehlauer, F., Tribius, S., Mehnert, A., & Rades, D. (2005). Healthrelated    quality of life in long term breast cancer survivors treated with breast conserving    therapy: impact of age at therapy. Breast Cancer Research and Treatment, 92,    217–222 </P>     ]]></body>
<body><![CDATA[<p> Goodwin, P.,Black, J.,Bordeleau, L., & Ganz, P.(2003). HealthRelated QualityofLife    Measurement in Randomized Clinical Trials in Breast Cancer— Taking Stock. Journal    of the National Cancer Institute, 95, (4), 263-281 </P>     <p> Guzelant A., Goksel T., Ozkok S., Tasbakan S., Aysan T. & Bottomley A. (2004).    The European Organization for Research and Treatment of Cancer QLQ-C30: an examination    into the cultural validity and reliability of the Turkish version of the EORTC    QLQ-C30. European Journal of Cancer Care, 13, 135–144 </P>     <p> Hjermstad, M., Fayers, P., Bjordal, K., & Kaasa, S.(1998). healthrelated quality    of ife in general Norwegian population assessed by the European Organization    for Research and Treatment of Cancer core qualityoflife questionnaire: the QLQ=C30(+3).    Journal of clinical oncology,16(3), 1188-1196. </P>     <p> King, M. (1996). The interpretation of scores from the EORTC quality of life    questionnaire QLQ-C30. Quality of Life Research, 5, 555-567 </P>     <p> Kobayashi,K., Takeda,F., Teramukai,S., Gotoh,I., Sakai,H., Yoneda,S., Noguchi,Y.,    Ogasawara, H., & Yoshida, K. (1998). A Crossvalidation of the European Organization    for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with    Lung Cancer. European Journal of Cancer, 34 (6), 810-815 </P>     <P> Leigh, S. (1992). Myths, monsters, and magic: personal perspectives and professional    challenges of survival. Oncology Nursing Forum, 19(10),1475-1480 </P>     <p> Lipscomb,J., Donaldson,M., Arora, N., Brown,M., Clauser, S., Potosky, A.,    Reeve, B., Rowland, J., Snyder, C., & Taplin,S.(2004) Cancer Outcomes Research.    Journal of the National Cancer Institute Monographs, 33, 178-197 </P>     <p> Mandelblatt, J., Armetta, C., Yabroff, K.,Liang,W., & Lawrence, W. (2004).Descriptive    Review of the Literature on Breast Cancer Outcomes: 1990 Through 2000. Journal    of the National Cancer Institute Monographs, 33, 8-44 </P>     <p> Mandelblatt,J., Lawrence,W., Cullen, J., Stanton, A., Krupnick,J., Kwan,L.,    & Ganz, P.(2006). Patterns of Care in EarlyStage Breast Cancer Survivors in    the First Year After Cessation of Active Treatment. Journal of clinical oncology,    24(1),77-84 </P>     <p> Mullan, F. (1985) Seasons of survival: Reflections of a physician with cancer.    New England Journal of Medicine, 313, 270–273. </P>     ]]></body>
<body><![CDATA[<p> National Cancer Institute (NCI) (2003). Cancer Control and Population Sciences:    Research Findings [online]. Assessed on December,18, 2007 at: <a href="http://dccps.nci.nih.gov/ocs/prevalence/index.html" target="_blank">http://dccps.nci.nih.gov/ocs/prevalence/index.html</a>  </P>     <p> Osoba D, Rodrigues G, Myles J, Zee B, Pater J. (1998). Interpreting the significance    of changes in healthrelated Quality of Life scores. Journal of Clinical Oncology,    16, 139– 144. </P>     <p> Osoba,D. Zee, B., Pater, J., Warr, D., Kaizer,L., & Latreille,J. (1994). Psychometric    properties and responsiveness of the EORTC Quality of Life in patiets with breast,    ovarian and lung cancer. Quality of Life Research, 3, 353-364 </P>     <p> Osoba,D., Aaronson, N., Zee, B., Sprangers, M. and te Velde, A. for the Study    Group on Quality of Life of the EORTC and the Symptom Control and Quality of    Life Committees of the NCI of Canada Clinical Trials Group (1997). Modification    of the EORTC QLQC30 (version 2.0) based on content validity and reliability    testing in large samples of patients with cancer. Quality of Life Research,    6, 103–108 </P>     <p> Parsons, S.,& Brown, A. (1998). Evaluation of Quality of Life of Childhood    Cancer Survivors: A Methodological Conundrum. Medical and Pediatric Oncology    Supplement, 1, 46–53 </P>     <p> Ringdal,G., & Ringdal, K. (2000).A followup of the quality of life in cancer    patients with different prognoses. Quality of Life Research, 9, 65-73 </P>     <p> Sprangers, M., & Schwartz, C. (1999). Integrating response shift into healthrelated    quality of life research: a theoretical model. Social Science and Medicine,    48 (11), 1507-1515. </P>     <p> Taylor, S. E. (1983). Adjustment to threatening events: A theory of cognitive    adaptation. American Psychologist, 38, 1161-1173. </P>     <p> Taylor, S., & Brown, J. (1988). Illusion and WellBeing: A Social Psychological    Perspective on Mental Health. Psyehologlcal Bulletin, 103 (2), 193-210 </P>     <p> Zebrack, B., & Zeltzer, L. (2003). Quality of life issues and cancer survivorship.    Current problems in cancer, 27(4), 198-211 </P>     ]]></body>
<body><![CDATA[<p> Zhao, H., & Kanda, K. (2000). Translation and validation of the Standard Chinese    version of the EORTC QLQC30. Quality of Life Research, 9, 129-137. </P>     <p>&nbsp;</P>     <p align="right">Recebido em 30 de Outubro de 2007 / aceite em 12 de Dezembro    de 2007 </P>      ]]></body><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aaronson]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmedzai]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Bergman]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Bullinger]]></surname>
<given-names><![CDATA[Cull]]></given-names>
</name>
<name>
<surname><![CDATA[Duez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[N.]]></surname>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[The European Organization for Research and Treatment of Cancer QLQ-C30: A qualityof lifeinstrument for use in international clinical trials in oncology]]></article-title>
<source><![CDATA[Journal of the National Cancer Institute]]></source>
<year>1993</year>
<volume>85</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>365-375</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
